Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.
Manuel Sánchez CánovasDavid Fernández GarayFrancisco Gómez MartínezElena Brozos VázquezMiriam Lobo de MenaSilvia García AdriánVilma Pacheco-BarcíaDiego Cacho LavinEva Martínez de CastroAna Manuela Martín Fernández de SoignieElia MartínezAna Belén Rúperez BlancoIgnacio García EscobarCarmen Salvador ColomaNoel Blaya BoludaMaría Esperanza Guirao GarcíaMariano Gambín ArronizAndrés J Muñoz MartínPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
The data from our series does not validate of the CoVID-TE as a model to predict thrombosis, hemorrhage, or mortality in cancer patients with Sars-Cov-2 infection.